InChI=1S/C22H32O4/c1-2-3-12-15-20(23)16-13-10-8-6-4-5-7-9-11-14-17-21(24)18-19-22(25)26/h3-5,8-14,16-17,20-21,23-24H,2,6-7,15,18-19H2,1H3,(H,25,26)/b5-4-,10-8-,11-9-,12-3-,16-13+,17-14+/t20-,21+/m0/s1 |
JKPUWSZSJINVLB-OSKNXYPTSA-N |
C(C(O)=O)C[C@@H](/C=C/C=C\C/C=C\C/C=C\C=C\[C@H](C/C=C\CC)O)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
View more via ChEBI Ontology
(4S,5E,7Z,10Z,13Z,15E,17S,19Z)-4,17-dihydroxydocosa-5,7,10,13,15,19-hexaenoic acid
|
(4S,5E,7Z,10Z,13Z,15E,17S,19Z)-4,17-dihydroxydocosahexaenoic acid
|
ChEBI
|
4S,17S-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid
|
LIPID MAPS
|
RvD6
|
SUBMITTER
|
14535278
|
Reaxys Registry Number
|
Reaxys
|
23991833
|
PubMed citation
|
Europe PMC
|
25139562
|
PubMed citation
|
Europe PMC
|
26019184
|
PubMed citation
|
Europe PMC
|
27121596
|
PubMed citation
|
Europe PMC
|
28765512
|
PubMed citation
|
Europe PMC
|
|